Foad, B., Adams, L. E., Litwin, A., and Hess, E. V. (1976) . Annals of the Rheumatic Diseases, 35, [407] [408] [409] [410] [411] [412] [413] [414] . Peripheral blood lymphocyte response to phytomitogens in systemic lupus erythematosus. The response of peripheral blood lymphocytes to the phytomitogens, PHA, Con A, and PWM, was evaluated in 30 SLE patients and in 30 age, sex, and race-matched controls using dose and time responses. The proliferative response to the three phytomitogens was not depressed in this group of subacute and chronic SLE patients. Active lupus nephritis and a slow acetylator phenotype were associated with a decreased lymphocyte response. The incidence of a slow acetylator phenotype in spontaneous SLE was 68 %. In interpreting the lymphocyte response to phytomitogens, the importance of a clear definition of the SLE group under study, the activity of the disease, and treatment status are emphasized.
Various parameters of cell-mediated immunity in systemic lupus erythematosus (SLE) have been reported by several workers with conflicting results. These have included the study of delayed hypersensitivity responses to various antigens (Friedman and others, 1960; Ores and Lange, 1964; Fardal and Winkelman, 1965; Chieregato and Faldarini, 1964; Azoury and others, 1966; Block and others, 1968; Abe and Homma, 1971; Goldman and others, 1972; Bitter and others, 1971; Horwitz, 1972; Hahn, Bagby, and Osterland, 1973; Rosenthal and Franklin, 1975) , the in vitro response of peripheral blood lymphocytes to phytomitogens and antigens (Patrucco, Rothfield, and Hirschhorn, 1967; Bitter and others, 1971; Horwitz, 1972; Goldman and others, 1972; Senyk and others, 1974; Suciu-Foca and others, 1974; Rosenthal and Franklin, 1975; Lockshin and others, 1975; Malave, Layrisse, and Layrisse, 1975) , the elaboration of macrophage inhibitory factor (Rocklin, Lewis, and David, 1970; Galanaud and others, 1971; Moulias and others, 1972; Abe and others, 1973; Rosenthal and Franklin, 1975) , blastic transformation of lymphocytes in mixed leucocyte culture (Hedberg and others, 1971; Wemet and others, 1973; Suciu-Foca and others, 1974) , and recently the absolute number and percentage ofcirculating T and B lymphocytes (Messner, Lindstrom, and Williams, 1973; Scheinberg and Cathcart, 1974; Lockshin and others, 1975) .
The reasons for the confficting data are not clear though there are a number of possible explanations. The SLE syndrome covers a wide spectrum of disease subsets varying in mode of presentation and severity of disease activity. In many of the above studies a careful definition of the SLE population was not given. The influence of treatment with corticosteroids and/or immunosuppressive agents on the immune response of SLE patients is difficult to distinguish from aberrations of the immune response caused by the disease itself. Also, these drugs may obscure disease activity. Another major difficulty in comparing data from various laboratories is the lack of standardization of the in vitro techniques utilized for measuring cell-mediated immunity. Several factors influence the proliferative response of peripheral blood lymphocytes to phytomitogens. Foad and others (1974) stressed the need for using age-matched controls in comparing populations and for performing dose and time response curves. Most other investigators have used undiluted phytohaemagglutinin and a culture duration of 3 days.
The present study of a group of SLE patients took many of these variables into account. The clinical status of the patient population was well defined. Dose and time response curves of peripheral blood lymphocytes to the three phytomitogens, phytohaemagglutinin-M (PHA-M), concanavalin-A (Con-A), and pokeweed mitogen (PWM), were performed and these data were correlated with disease activity, treatment status, kidney disease, and hepatic acetylation rate. The in vitro lymphocyte response data expressed both as counts per minute (cpm) and as ratios of mitogen stimulated cultures divided by control cultures.
Materials and methods

MITOGENS
The concentration of mitogens was similar to that used previously (Foad and others, 1974 The method used was that described previously (Foad and others, 1974) . Briefly, heparinized venous blood was sedimented with 5 % dextran. Leucocytes from the plasma were washed three times with minimum essential medium (MEM) and the cells diluted with the appropriate amount of MEM with gentamicin which contained 20 % fetal calf serum and L-glutamine to yield a final concentration of 500 000 mononuclear cells/ml. 4 mil aliquots of the cell suspension were placed into sterile disposable glass culture tubes containing the proper concentration of the three mitogens. The cultures were incubated at 37°C in a moist atmosphere of 95 % air and 5 % CO2. After the proper incubation period (3 and 5 days for mitogens and controls), the cells were pulsed for 2 hours with 4 ACi 3H-thymidine (6-0 Ci/mmol per h). After the 2-hour pulse, the cultures were chilled, precipitated with 5% trichloroacetic acid, washed, and solubilized with hydroxide of Hyamine (10 x). The vials were counted in a liquid scintillation counter.
PATIENTS AND CONTROLS
Thirty SLE patients and 30 controls matched for age, sex, and race were studied. The age range in the SLE group was 17-73 years with a mean of 36-7 years, and in the control group 17-66 years with a mean of 36-7. There were 24 females and 6 males in the SLE group, and 23 females and 7 males in the control group. 16 were white and 14 black in both the SLE and the control groups.
The clinical features of the SLE group are shown in Table III gives the results of lymphocyte formation to Con A in SLE and control groups as median ratios and Acpm. Using the Mann-Whitney test, the SLE group showed a significantly higher response compared to the control group at a Con A concentration of 50 ,ug in 3-day cultures (P <O 05). However, no differences between the two groups were observed when the results were expressed as Acpm. Analysis of data by Student's 't' test again showed the same findings.
PWM Table IV gives the results of lymphocyte transformation to PWM. Using the Mann-Whitney test, the SLE group showed no significant differences compared to the control group using median ratios. However, using the Acpm, the SLE group showed a significantly higher response compared to the control group at the PWM concentration of 1000 [±g Slow acetylators of sulphamethazine had a lower lymphocyte response to PHA-M, Con A, and PWM, both at 3-and 5-day cultures compared to rapid acetylators (Fig. 4) . This difference was seen with all concentrations of phytomitogens; P = 0X06 and 0X08 for PHA-M at 1000 and 200 ,ug and 3-day The sulphamethazine test is a reflection of the activity of the enzyme acetyl transferase which is a genetically determined trait. Hydrallazine-induced SLE is seen almost entirely in those individuals who are 'slow acetylators'. Thus, activity of this enzyme was sought in our SLE patients as a potential genetic marker for SLE. A high incidence of 'slow acetylators' was present in our SLE group; 68% compared to the reported incidence of 50% in the general population (Price Evans and White, 1964) . Reidenberg and Martin (1974) have also determined the acetylator phenotype by measuring the ratio of monoacetyl dapsone to dapsone in plasma of SLE patients 3 hours after they received a single oral dose of 100 mg dapsone. 10 of their 14 SLE patients were slow acetylators. The slow acetylator phenotype in our study was associated with a depressed lymphocyte response to phytomitogens. The reason for this association is not clear. The difference in lymphocyte culture responses within the SLE group were statistically significant only at some concentrations of phytomitogens in 3-or 5-day cultures. Without performing dose and time response curves, some of the significant differences would have been missed. In the present study lymphocyte responsiveness to phytomitogens was unimpaired. This finding agrees with the previous report from this laboratory (Goldman and others, 1972) and the finding of Senyk and others (1974) (Rosenthal and Franklin, 1975) do show impairment. This discrepancy may be partially explained by the study of Grossman and others (1975) which showed that acutely ill patients with a variety of diseases have transient depression of cell-mediated immunity.
